Loading
Sharpe FinanceDID YOU KNOWnext in 7s
Most depeg events happen on weekends. Market makers don't sleep — they just close their books.
Morpho Blue · Aave V3 · 11 chains · scoring refreshed every 5 min
Most depeg events happen on weekends. Market makers don't sleep — they just close their books.
sUSDe supply on Aave V3 (Ethereum). Read-only on Sharpe — deposits, withdrawals, and borrows execute on app.aave.com. We surface parameters, rates, and risk so you can compare this reserve against Morpho vaults on the same asset cohort.
Plain-English summary of this vault — what it does, who runs it, where the yield comes from, and what could break it. Generated from the same deterministic inputs shown elsewhere on this page; the numbers are the source, this is just the explanation.
You deposit sUSDe (Ethena's staked USDe synthetic dollar) and it gets lent to borrowers on Ethereum. You earn the variable borrow rate paid by borrowers, currently 0%, net of Aave's 20% fee. sUSDe is borrow-only—it cannot secure loans—so it exists purely as a yield-generating reserve. All $303M supplied is available to withdraw at any time.
Aave governance has not flagged sUSDe with pause, freeze, isolation, or silos, and the risk score of 15/100 sits well below caution thresholds.
Supply APY is 0% because borrowing demand for sUSDe is absent (0% utilization). Borrowers are not using sUSDe as a debt instrument; until that changes, deposits earn nothing.
The sole material risk is structural: sUSDe has no active borrow market. If borrowing demand does not emerge, supply APY remains zero indefinitely. Secondary risk is Ethena's operational continuity and the USDe peg itself, though no depeg signal is active.
Avoid if seeking yield. Only deposit if you need sUSDe's liquidity on Ethereum and accept zero return as the cost of that access.
On Aave V3, a supplier can withdraw up to the reserve's available liquidity instantly. Above that, the withdrawal must wait for borrowers to repay or new suppliers to deposit. Markets at 95%+ utilization can keep large redemptions waiting for hours to days at current rates.
Reserve parameters are set by Aave governance (BGD Labs + Aave Chan Initiative + Risk Council). Listings, caps, IRM curves, and LLTVs change through on-chain votes.
This reserve isn't usable as collateral, so LTV / Liquidation LLTV / liquidation bonus don't apply. Borrowers can take it against other collateral; suppliers earn the variable rate driven by borrow demand.
On Aave V3, supply APY = borrow APY × utilization × (1 − reserve factor). There is no curator skim; the only intermediation cost is the reserve factor, which funds the Aave treasury. No emissions slice in v1 of this integration — the headline is fully sustainable.
Aave V3 reserves carry parameter risk (LTV/LLTV adequacy vs collateral volatility), liquidity risk (high utilization slows exit), and depeg risk on the underlying. Governance can pause / freeze / adjust caps in response to incidents. Sharpe's full risk decomposition for Aave reserves rolls in v1.1.
How the composite risk score breaks down. Every number traces to an explicit input — /methodology documents each factor's formula.
Per-collateral decomposition: Sharpe-style realized σ from 30 daily log returns, blended 50/50 with the asset-taxonomy tier fallback. Phase 2 will replace the tier slot with liquidity depth, mechanism classification, and holder concentration. Methodology in /methodology.
The honest version. Every structural failure mode this vault is exposed to, ranked by severity. If you want to know whether to invest, start here.
Aave V3 prices and liquidations route through Chainlink's aggregator feed for this asset. A stale, manipulated, or wrong-side update is the protocol's largest single-point-of-failure for this reserve. Chainlink has a strong track record but the failure mode is binary.
Aave V3 has been live since March 2022 with significant TVL and continuous third-party audits. Historical incidents have been contained but the protocol surface is large (Pool / aTokens / debtTokens / IRM / Oracle / UiHelpers). Treat as bounded but non-zero tail risk.